Clinical Biotechnology Research In… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2015

Legal Domicile

Phone

8437242958

Tax Period

2024-01-01 to 2024-12-31

Clinical Biotechnology Research Institute at RSFH, founded in 2015, is a small nonprofit in the Medical Research sector that reported $585K in total revenue in fiscal year 2024. Revenue surged 170% from the prior year, signaling strong growth momentum. Expenses of $910K exceeded revenue, resulting in a 56% operating deficit.

Mission

Healing all people with compassion, faith, and excellence.

Program Service Accomplishments

Program 1

Expenses: $738,281 Revenue: $585,349

The CBRI is comprised of the Clinical Research Program and the Innovation Center. The robust research program allows patients access to the newest treatments and clinical trials available for varied conditions. It also creates an atmosphere of innovation, where we are building partnerships for the development of new therapies and establishing an intellectual research hub in the Lowcountry. The Innovation Center was created to turn biotechnology ideas into products/businesses by recruiting ideas from physicians and researchers all over the world. Ideas that are submitted will be evaluated by the Innovation Center team to determine feasibility and market potential. If the idea is selected, the team will put together a development plan.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $585,336

Investment Income $0

Other Revenue $13

TOTAL REVENUE $585,349

Expense Breakdown

Grants Paid $0

Salaries & Benefits $700,484

Fundraising Expenses $0

Program Expenses $738,281

Other Expenses $209,740

TOTAL EXPENSES $910,224

Year-over-Year Comparison

	2024	2023	Change
Revenue	$585,349	$217,003	+1.7%
Expenses	$910,224	$995,572	-0.1%
Net Income	$-324,875	$-778,569	-0.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$3,653,207

Total Directors

$12,300,619

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Edward McKelvey	Board Chair	0.5	Officer Director	$0	$0	$0
Megan Baker MD	Board Member (End 08/24); Interim President RSF Foundation (Beg 10/24)	0.5	Officer Director	$0	$78,516	$980,327
Scott Woodfield MD	Board Vice Chair, RSFPP Physician	0.5	Officer Director	$0	$56,060	$1,223,580
Brian Yanofchick	Board Member, Chief Sponsorship Officer-BSMH	0.5	Director	$0	$23,245	$739,855
Charles Ford Rivers III	Board Member	0.5	Director	$0	$0	$0
Cheryl Dalton-Norman	Board Member (Beg 05/2024), President - Conduit Health Partners	0.5	Director	$0	$39,737	$620,247
Eric Smith	Board Member (Beg 05/2024), CFO Ambulatory Finance - BSMH	0.5	Director	$0	$156,887	$1,011,638
Henry West MD	Board Member (Beg 01/24), Surgeon - RSFPP	0.5	Director	$0	$42,490	$590,653
John Spratt MD	Board Member, Physician	0.5	Director	$0	$59,408	$950,812
JOSEPH GAGE JR JD	Board Member, BSMH Chief HR Officer	0.5	Director	$0	$298,294	$1,778,346
Karen Wrighten	Board Member	0.5	Director	$0	$0	$0
Kay W Phillips PhD	Board Member (End 05/24)	0.5	Director	$0	$0	$0
Michael Lutes	Board Member (Beg 05/2024), Richmond Market President - BSMH	0.5	Director	$0	$320,047	$1,433,183
Roberta Pinckney	Board Member (End 05/24)	0.5	Director	$0	$0	$0
Susan Datta MD	Board Member (End 12/24), Internist - RSFPP	0.5	Director	$0	$17,475	$432,813
Wael Haidar MD	Board Member, BSMH CHIEF CLINICAL OFFICER	0.5	Director	$0	$551,052	$2,539,165
Brad Grosteffon	Interim CFO/Treasurer (End 08/24)	0.5	Officer	$0	$65,548	$584,779
Joseph DeLeon	President/CEO RSFH (Beg 08/24)	0.5	Officer	$0	$70,055	$602,447
Rebecca Tucker	CFO/Treasurer (Beg 08/24)	0.5	Officer	$0	$27,846	$262,074
Bree Maddray	Lead RN Clinical Research	40.0	Highest	$139,476	$43,229	$182,705
Julia Johnson	Research Manager	40.0	Highest	$108,644	$22,524	$131,168
Brian Cuddy MD	Former Chairperson, Neurosurgeon - RSFPP	0.0		$0	$55,882	$1,185,598
Jeffrey DiLisi	Former President/CEO RSFH	0.0		$0	$11,719	$2,068,411

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$585,349	$910,224	$83,730	$-324,875
2023	$217,003	$995,572	$25,001	$-778,569
2022	$256,423	$746,169	$34,078	$-489,746
2021	$843,816	$1,951,615	$257,664	$-1,107,799
2020	$2,562,340	$3,305,714	$1,052,058	$-743,374
2019	$3,226,061	$3,103,021	$1,067,592	$123,040
2018	$3,450,434	$3,082,254	$1,740,143	$368,180

Clinical Biotechnology Research Institute at RSFH